CLINICAL_TRIALS
trial_result
· 2013-04-19
Clinical Trial Update: A Trial of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis [NA]
Summary
Completed clinical trial evaluating aprepitant for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis; results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Pancreatitis | NA | Status: COMPLETED | Results posted: 2013-04-19